Genetic link between childhood brain disorder and Parkinson’s disease in adults

The study, published in the Annals of Neurology, looked at a gene called EPG5. Errors in this gene are already known to cause Vici syndrome – a rare and severe inherited neurodevelopmental condition that presents early in life and affects multiple organ systems.

Now researchers at UCL, King’s College London, the University of Cologne and the Max Planck Institute for Biology of Ageing have found that errors in the same gene are linked to changes in nerve cells that lead to more common age-related conditions like Parkinson’s disease and dementia.

Dr Reza Maroofian, co-first author of the study from the UCL Queen Square Institute of Neurology, said: “Our findings link EPG5 dysfunction to Parkinson’s disease, highlighting how neurodevelopmental and neurodegenerative disorders can be mechanistically interconnected and add to a growing list of such conditions. This study underscores how insights from rare paediatric brain disorders can inform our understanding of more common adult-onset neurodegenerative diseases, such as Parkinson’s and dementia.”

In the largest study of its kind to date, the team of scientists analysed clinical and genetic data from 211 individuals from across the world with rare errors in EPG5. They found that the effects of these genetic errors are broader and more variable than previously known – while some individuals had life-limiting forms of Vici syndrome identified before or shortly after birth, others showed much milder symptoms, including delay in movement, speech, and learning.

The researchers also discovered that some of the patients included in the study went on to develop a breakdown of nerve cells in adolescence or early adulthood that led to Parkinson’s disease and dementia. Brain scans analysed in some cases showed additional iron build-up in the brain, a feature of other, closely linked neurodevelopmental disorders.

Professor Heinz Jungbluth (King’s College London), lead and co-senior author of the study, said: “This research, supported by patient organisations, was prompted by our earlier observation of an apparent increased Parkinson’s disease risk in relatives of children with Vici syndrome, after our team at King’s had found EPG5 to be a driver of this condition.

“Our work shows that, whilst rarely considered a priority, research into (ultra)rare conditions such as Vici syndrome (where fewer than 10 children are currently known to have the condition in the UK) may provide vital insights into much more common disorders and have substantial public health benefits. 

“Understanding the causes of these devastating and often life-limiting diseases is essential for therapy development and thus offers hope for patients and their families.” 

The EPG5 gene is involved in an important cellular process called autophagy, where the cell breaks down unwanted or damaged components and either recycles them into new parts or disposes of them. The protein made by EPG5 is involved in the last stage of this process – attaching the parts for disposal to the cell’s waste disposal unit for removal from the cell.

To explore the biology underpinning their findings, the researchers used patient-derived cells and model organisms, including mice and the tiny roundworm C. elegans, and introduced errors into EPG5. These experiments showed that genetic errors in the gene disrupt the cell’s ability to clear damaged components from the cell, leading to the build-up of proteins closely associated with Parkinson’s disease.

Professor Jungbluth, who is also a Consultant Paediatric Neurologist at Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, said: “Using the example of EPG5, our findings suggest a life-time continuum of early-onset neurodevelopmental and late-onset neurodegenerative disorders, and more specifically an intriguing link between aberrant nerve development and degeneration linked in the same fundamental cellular mechanism preserved throughout different species.”

Dr Manolis Fanto (King’s College London), co-senior author of the study, added: “This project highlights the importance of collaboration between basic and clinical neuroscientists to unravel the complex mechanistic consequences of inherited genetic conditions throughout all life stages.”

The study provides new understanding of how errors in autophagy can underpin a range of lifelong neurological conditions and may help pave the way for future treatments that target these shared drivers of disease.

The research team also included Dr Kritarth Singh and Professor Michael Duchen (both UCL Biosciences) as co-first author and co-senior author, and Professor Henry Houlden (UCL Queen Square Institute of Neurology) as co-senior author.

Links

• Research paper in Annals of Neurology
• Dr Reza Maroofian’s academic profile
• Dr Kritarth Singh’s academic profile
• Professor Henry Houlden’s academic profile
• Professor Michael Duchen’s academic profile
• UCL Neurogenetics Lab
• UCL Queen Square Institute of Neurology
• UCL Biosciences

Image

• MRI scan. Credit: iStock / Ildar Imashev

Media contact

Chris Lane

tel: +44 20 7679 9222  / +44 (0) 7717 728648

E: chris.lane [at] ucl.ac.uk